Relative Bioavailability and Food Effect Following Single Oral Dose of Darigabat Tablet Formulations in Healthy Participants
Clinical trial NCT05123079 · COMPLETED
Trial details
- NCT number
- NCT05123079
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-02
- Primary completion
- 2021-11-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.